Virtu Financial LLC Liminal Bio Sciences Inc. Transaction History

Virtu Financial LLC

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 May 17, 2022	SELL	$0.82 - $1.13 $15,211 - $20,961	-18,550 Closed	0 $0
Q4 2021 Feb 17, 2022	SELL	$0.92 - $2.2 $7,148 - $17,094	-7,770 Reduced 29.52%	18,550 $20,000
Q3 2021 Nov 12, 2021	BUY	$2.15 - $3.92 $27,511 - $50,160	12,796 Added 94.62%	26,320 $60,000
Q2 2021 Sep 17, 2021	SELL	$3.75 - $5.17 $34,132 - $47,057	-9,102 Reduced 40.23%	13,524 $53,000
Q1 2021 May 19, 2021	SELL	$3.94 - $6.43 $49,829 - $81,320	-12,647 Reduced 35.85%	22,626 $93,000
Q4 2020 Feb 24, 2021	BUY	$3.68 - $11.02 $75,443 - $225,921	20,501 Added 138.78%	35,273 $148,000
Q3 2020 Dec 11, 2020	BUY	$10.51 - $23.79 $155,253 - $351,425	14,772 New	14,772 $164,000

234

Ticker LMNL
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 31,042,600
Description
Liminal BioSciences Inc., a clinical-stage biopharmaceutical company, focuses on the development of novel small molecule drug therapeutics for inflammatory, fibrotic, and metabolic diseases in Canada and the United Kingdom. The company's lead product candidate is fezagepras (PBI-4050), which has been completed Phase I clinical trial for the trea...

Get notified when there are updates to the investment portfolio of Virtu Financial LLC, based on Form 13F filings with the SEC.

Stay updated on Virtu Financial LLC with notifications on news.